Looks at how high blood pressure is treated in Brazil's public primary care clinics
Reviews past health records of adults with high blood pressure treated in public primary care.
Plain-language title generated from the registry record
Registry title: Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care System
Key facts
- Where
- Florianópolis, BrazilSee the site
Where in Brazil
- FlorianópolisFlorianópolis, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AstraZeneca
- Trial code
- NCT07361276
- Record updated
- 22 October 2026
- Original description
This is a retrospective observational cohort study based on secondary use of routinely collected electronic health data. The design was selected to enable population-level characterisation of treatment patterns and clinical inertia (both diagnostic and therapeutic) in the management of hypertension across diverse settings in Brazil's public primary care system (SUS).Read full original descriptionShow less
Clinical Landscape of Epidemiology and Assessment of Results in Hypertension
This is a retrospective observational cohort study based on secondary use of routinely collected electronic health data. The design was selected to enable population-level characterisation of treatment patterns and clinical inertia (both diagnostic and therapeutic) in the management of hypertension across diverse settings in Brazil's public primary care system (SUS).
Inclusion: Age ≥18 years at the time of Hypertension diagnosis; Hypertension diagnosis as retrieved from registered ICD codes or CIAP Codes (primary care codes) in the EMR , OR At least two blood pressure measurements ≥140/90 mmHg during the study period. The blood measurements should be consecutive and obtained within a 30 days period; Continuous follow-up in the same municipality for at least 6 months after index measurement; Availability of structured EMR data including clinical encounters, diagnoses, and prescriptions.
Exclusion: Patients with incomplete data or not traceable in the registration systems.